
### [MONDO:0019518](http://purl.obolibrary.org/obo/MONDO_0019518)
**Label:** Waardenburg-Shah syndrome

**Subclasses:** [MONDO:0013201](http://purl.obolibrary.org/obo/MONDO_0013201) (Waardenburg syndrome type 4B), [MONDO:0010192](http://purl.obolibrary.org/obo/MONDO_0010192) (Waardenburg syndrome type 4A), [MONDO:0013202](http://purl.obolibrary.org/obo/MONDO_0013202) (Waardenburg syndrome type 4C), 

**Mapped go classes:** [GO:0000978](http://purl.obolibrary.org/obo/GO_0000978) (RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0060406](http://purl.obolibrary.org/obo/GO_0060406) (positive regulation of penile erection), [GO:0007497](http://purl.obolibrary.org/obo/GO_0007497) (posterior midgut development), [GO:0000980](http://purl.obolibrary.org/obo/GO_0000980) (RNA polymerase II distal enhancer sequence-specific DNA binding), [GO:0004930](http://purl.obolibrary.org/obo/GO_0004930) (G-protein coupled receptor activity), [GO:0048484](http://purl.obolibrary.org/obo/GO_0048484) (enteric nervous system development), [GO:0022010](http://purl.obolibrary.org/obo/GO_0022010) (central nervous system myelination), [GO:0022011](http://purl.obolibrary.org/obo/GO_0022011) (myelination in peripheral nervous system), [GO:0045892](http://purl.obolibrary.org/obo/GO_0045892) (negative regulation of transcription, DNA-templated), [GO:0048246](http://purl.obolibrary.org/obo/GO_0048246) (macrophage chemotaxis), [GO:0045893](http://purl.obolibrary.org/obo/GO_0045893) (positive regulation of transcription, DNA-templated), [GO:0001701](http://purl.obolibrary.org/obo/GO_0001701) (in utero embryonic development), [GO:0070285](http://purl.obolibrary.org/obo/GO_0070285) (pigment cell development), [GO:0043473](http://purl.obolibrary.org/obo/GO_0043473) (pigmentation), [GO:0050678](http://purl.obolibrary.org/obo/GO_0050678) (regulation of epithelial cell proliferation), [GO:0007422](http://purl.obolibrary.org/obo/GO_0007422) (peripheral nervous system development), [GO:0003100](http://purl.obolibrary.org/obo/GO_0003100) (regulation of systemic arterial blood pressure by endothelin), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0000981](http://purl.obolibrary.org/obo/GO_0000981) (RNA polymerase II transcription factor activity, sequence-specific DNA binding), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0048016](http://purl.obolibrary.org/obo/GO_0048016) (inositol phosphate-mediated signaling), [GO:0019233](http://purl.obolibrary.org/obo/GO_0019233) (sensory perception of pain), [GO:0031620](http://purl.obolibrary.org/obo/GO_0031620) (regulation of fever generation), [GO:0051930](http://purl.obolibrary.org/obo/GO_0051930) (regulation of sensory perception of pain), [GO:0043406](http://purl.obolibrary.org/obo/GO_0043406) (positive regulation of MAP kinase activity), [GO:0014044](http://purl.obolibrary.org/obo/GO_0014044) (Schwann cell development), [GO:0014043](http://purl.obolibrary.org/obo/GO_0014043) (negative regulation of neuron maturation), [GO:0008284](http://purl.obolibrary.org/obo/GO_0008284) (positive regulation of cell proliferation), [GO:0044212](http://purl.obolibrary.org/obo/GO_0044212) (transcription regulatory region DNA binding), [GO:0042310](http://purl.obolibrary.org/obo/GO_0042310) (vasoconstriction), [GO:0042311](http://purl.obolibrary.org/obo/GO_0042311) (vasodilation), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0005179](http://purl.obolibrary.org/obo/GO_0005179) (hormone activity), [GO:0021772](http://purl.obolibrary.org/obo/GO_0021772) (olfactory bulb development), [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function), [GO:0048265](http://purl.obolibrary.org/obo/GO_0048265) (response to pain), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0035815](http://purl.obolibrary.org/obo/GO_0035815) (positive regulation of renal sodium excretion), [GO:0003705](http://purl.obolibrary.org/obo/GO_0003705) (transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding), [GO:0017046](http://purl.obolibrary.org/obo/GO_0017046) (peptide hormone binding), [GO:0019229](http://purl.obolibrary.org/obo/GO_0019229) (regulation of vasoconstriction), [GO:0032269](http://purl.obolibrary.org/obo/GO_0032269) (negative regulation of cellular protein metabolic process), [GO:0035810](http://purl.obolibrary.org/obo/GO_0035810) (positive regulation of urine volume), [GO:0046928](http://purl.obolibrary.org/obo/GO_0046928) (regulation of neurotransmitter secretion), [GO:0048709](http://purl.obolibrary.org/obo/GO_0048709) (oligodendrocyte differentiation), [GO:0086100](http://purl.obolibrary.org/obo/GO_0086100) (endothelin receptor signaling pathway), [GO:0046887](http://purl.obolibrary.org/obo/GO_0046887) (positive regulation of hormone secretion), [GO:0042045](http://purl.obolibrary.org/obo/GO_0042045) (epithelial fluid transport), [GO:1904888](http://purl.obolibrary.org/obo/GO_1904888) (cranial skeletal system development), [GO:0048546](http://purl.obolibrary.org/obo/GO_0048546) (digestive tract morphogenesis), [GO:0003682](http://purl.obolibrary.org/obo/GO_0003682) (chromatin binding), [GO:0005741](http://purl.obolibrary.org/obo/GO_0005741) (mitochondrial outer membrane), [GO:0008217](http://purl.obolibrary.org/obo/GO_0008217) (regulation of blood pressure), [GO:0046888](http://purl.obolibrary.org/obo/GO_0046888) (negative regulation of hormone secretion), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:0031965](http://purl.obolibrary.org/obo/GO_0031965) (nuclear membrane), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0001934](http://purl.obolibrary.org/obo/GO_0001934) (positive regulation of protein phosphorylation), [GO:0005739](http://purl.obolibrary.org/obo/GO_0005739) (mitochondrion), [GO:0030593](http://purl.obolibrary.org/obo/GO_0030593) (neutrophil chemotaxis), [GO:0032496](http://purl.obolibrary.org/obo/GO_0032496) (response to lipopolysaccharide), [GO:0010001](http://purl.obolibrary.org/obo/GO_0010001) (glial cell differentiation), [GO:0035645](http://purl.obolibrary.org/obo/GO_0035645) (enteric smooth muscle cell differentiation), [GO:0010460](http://purl.obolibrary.org/obo/GO_0010460) (positive regulation of heart rate), [GO:1901381](http://purl.obolibrary.org/obo/GO_1901381) (positive regulation of potassium ion transmembrane transport), [GO:0048839](http://purl.obolibrary.org/obo/GO_0048839) (inner ear development), [GO:0030072](http://purl.obolibrary.org/obo/GO_0030072) (peptide hormone secretion), [GO:0045840](http://purl.obolibrary.org/obo/GO_0045840) (positive regulation of mitotic nuclear division), [GO:0061138](http://purl.obolibrary.org/obo/GO_0061138) (morphogenesis of a branching epithelium), [GO:0006885](http://purl.obolibrary.org/obo/GO_0006885) (regulation of pH), [GO:0006368](http://purl.obolibrary.org/obo/GO_0006368) (transcription elongation from RNA polymerase II promoter), [GO:1990841](http://purl.obolibrary.org/obo/GO_1990841) (promoter-specific chromatin binding), [GO:0048840](http://purl.obolibrary.org/obo/GO_0048840) (otolith development), [GO:0032808](http://purl.obolibrary.org/obo/GO_0032808) (lacrimal gland development), [GO:0001190](http://purl.obolibrary.org/obo/GO_0001190) (transcriptional activator activity, RNA polymerase II transcription factor binding), [GO:0019722](http://purl.obolibrary.org/obo/GO_0019722) (calcium-mediated signaling), [GO:0031315](http://purl.obolibrary.org/obo/GO_0031315) (extrinsic component of mitochondrial outer membrane), [GO:0014037](http://purl.obolibrary.org/obo/GO_0014037) (Schwann cell differentiation), [GO:0007186](http://purl.obolibrary.org/obo/GO_0007186) (G-protein coupled receptor signaling pathway), [GO:0030182](http://purl.obolibrary.org/obo/GO_0030182) (neuron differentiation), [GO:0014032](http://purl.obolibrary.org/obo/GO_0014032) (neural crest cell development), [GO:0002690](http://purl.obolibrary.org/obo/GO_0002690) (positive regulation of leukocyte chemotaxis), [GO:0002052](http://purl.obolibrary.org/obo/GO_0002052) (positive regulation of neuroblast proliferation), [GO:0004871](http://purl.obolibrary.org/obo/GO_0004871) (signal transducer activity), [GO:0031702](http://purl.obolibrary.org/obo/GO_0031702) (type 1 angiotensin receptor binding), [GO:0001755](http://purl.obolibrary.org/obo/GO_0001755) (neural crest cell migration), [GO:0010626](http://purl.obolibrary.org/obo/GO_0010626) (negative regulation of Schwann cell proliferation), [GO:0050880](http://purl.obolibrary.org/obo/GO_0050880) (regulation of blood vessel size), [GO:0031708](http://purl.obolibrary.org/obo/GO_0031708) (endothelin B receptor binding), [GO:0010628](http://purl.obolibrary.org/obo/GO_0010628) (positive regulation of gene expression), [GO:0014826](http://purl.obolibrary.org/obo/GO_0014826) (vein smooth muscle contraction), [GO:0010468](http://purl.obolibrary.org/obo/GO_0010468) (regulation of gene expression), [GO:0071600](http://purl.obolibrary.org/obo/GO_0071600) (otic vesicle morphogenesis), [GO:0050768](http://purl.obolibrary.org/obo/GO_0050768) (negative regulation of neurogenesis), [GO:0030334](http://purl.obolibrary.org/obo/GO_0030334) (regulation of cell migration), [GO:0019934](http://purl.obolibrary.org/obo/GO_0019934) (cGMP-mediated signaling), [GO:0014003](http://purl.obolibrary.org/obo/GO_0014003) (oligodendrocyte development), [GO:0004962](http://purl.obolibrary.org/obo/GO_0004962) (endothelin receptor activity), [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm), [GO:0000122](http://purl.obolibrary.org/obo/GO_0000122) (negative regulation of transcription by RNA polymerase II), [GO:0048066](http://purl.obolibrary.org/obo/GO_0048066) (developmental pigmentation), [GO:0050935](http://purl.obolibrary.org/obo/GO_0050935) (iridophore differentiation), [GO:0050931](http://purl.obolibrary.org/obo/GO_0050931) (pigment cell differentiation), [GO:0014015](http://purl.obolibrary.org/obo/GO_0014015) (positive regulation of gliogenesis), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0007165](http://purl.obolibrary.org/obo/GO_0007165) (signal transduction), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0007166](http://purl.obolibrary.org/obo/GO_0007166) (cell surface receptor signaling pathway), [GO:0045597](http://purl.obolibrary.org/obo/GO_0045597) (positive regulation of cell differentiation), [GO:0048469](http://purl.obolibrary.org/obo/GO_0048469) (cell maturation), [GO:0007200](http://purl.obolibrary.org/obo/GO_0007200) (phospholipase C-activating G-protein coupled receptor signaling pathway), [GO:0008134](http://purl.obolibrary.org/obo/GO_0008134) (transcription factor binding), [GO:0048589](http://purl.obolibrary.org/obo/GO_0048589) (developmental growth), [GO:0006874](http://purl.obolibrary.org/obo/GO_0006874) (cellular calcium ion homeostasis), [GO:0007204](http://purl.obolibrary.org/obo/GO_0007204) (positive regulation of cytosolic calcium ion concentration), [GO:0090090](http://purl.obolibrary.org/obo/GO_0090090) (negative regulation of canonical Wnt signaling pathway), [GO:0030318](http://purl.obolibrary.org/obo/GO_0030318) (melanocyte differentiation), [GO:0048752](http://purl.obolibrary.org/obo/GO_0048752) (semicircular canal morphogenesis), [GO:0043066](http://purl.obolibrary.org/obo/GO_0043066) (negative regulation of apoptotic process), [GO:0045121](http://purl.obolibrary.org/obo/GO_0045121) (membrane raft), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0048070](http://purl.obolibrary.org/obo/GO_0048070) (regulation of developmental pigmentation), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0030154](http://purl.obolibrary.org/obo/GO_0030154) (cell differentiation), [GO:0010961](http://purl.obolibrary.org/obo/GO_0010961) (cellular magnesium ion homeostasis), [GO:0031643](http://purl.obolibrary.org/obo/GO_0031643) (positive regulation of myelination), 

**Class expressions from DL-Learner:**

- Thing 53.89%
- [GO:0048246](http://purl.obolibrary.org/obo/GO_0048246) (macrophage chemotaxis) 51.35%
- [GO:0030593](http://purl.obolibrary.org/obo/GO_0030593) (neutrophil chemotaxis) 51.35%
- [GO:0071621](http://purl.obolibrary.org/obo/GO_0071621) (granulocyte chemotaxis) and [GO:1990266](http://purl.obolibrary.org/obo/GO_1990266) (neutrophil migration) 51.35%
- [GO:0060326](http://purl.obolibrary.org/obo/GO_0060326) (cell chemotaxis) and [GO:1990266](http://purl.obolibrary.org/obo/GO_1990266) (neutrophil migration) 51.35%
- [GO:0060326](http://purl.obolibrary.org/obo/GO_0060326) (cell chemotaxis) and [GO:1905517](http://purl.obolibrary.org/obo/GO_1905517) (macrophage migration) 51.35%
- [GO:0030595](http://purl.obolibrary.org/obo/GO_0030595) (leukocyte chemotaxis) and [GO:1990266](http://purl.obolibrary.org/obo/GO_1990266) (neutrophil migration) 51.35%
- [GO:0030595](http://purl.obolibrary.org/obo/GO_0030595) (leukocyte chemotaxis) and [GO:1905517](http://purl.obolibrary.org/obo/GO_1905517) (macrophage migration) 51.35%
- [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) 42.15%
- [GO:0071621](http://purl.obolibrary.org/obo/GO_0071621) (granulocyte chemotaxis) 36.71%
- [GO:0060326](http://purl.obolibrary.org/obo/GO_0060326) (cell chemotaxis) and [GO:0097530](http://purl.obolibrary.org/obo/GO_0097530) (granulocyte migration) 36.71%
- [GO:0030595](http://purl.obolibrary.org/obo/GO_0030595) (leukocyte chemotaxis) and [GO:0097530](http://purl.obolibrary.org/obo/GO_0097530) (granulocyte migration) 36.71%
- [GO:0071621](http://purl.obolibrary.org/obo/GO_0071621) (granulocyte chemotaxis) and ([GO:0005288](http://purl.obolibrary.org/obo/GO_0005288) (null) or [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process)) 36.71%
- [GO:0071621](http://purl.obolibrary.org/obo/GO_0071621) (granulocyte chemotaxis) and ([GO:0005286](http://purl.obolibrary.org/obo/GO_0005286) (null) or [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process)) 36.71%
- [GO:0071621](http://purl.obolibrary.org/obo/GO_0071621) (granulocyte chemotaxis) and ([GO:0005285](http://purl.obolibrary.org/obo/GO_0005285) (null) or [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process)) 36.71%


